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1Background and Purpose—Anxiety after stroke is common and disabling. Stroke trialists have treated anxiety as a homogenous 
condition, and intervention studies have followed suit, neglecting the different treatment approaches for phobic and 
generalized anxiety. Using diagnostic psychiatric interviews, we aimed to report the frequency of phobic and generalized 
anxiety, phobic avoidance, predictors of anxiety, and patient outcomes at 3 months poststroke/transient ischemic attack.
Methods—We followed prospectively a cohort of new diagnosis of stroke/transient ischemic attack at 3 months with a 
telephone semistructured psychiatric interview, Fear Questionnaire, modified Rankin Scale, EuroQol-5D5L, and Work 
and Social Adjustment Scale.
Results—Anxiety disorder was common (any anxiety disorder, 38 of 175 [22%]). Phobic disorder was the predominant 
anxiety subtype: phobic disorder only, 18 of 175 (10%); phobic and generalized anxiety disorder, 13 of 175 (7%); and 
generalized anxiety disorder only, 7 of 175 (4%). Participants with anxiety disorder reported higher level of phobic 
avoidance across all situations on the Fear Questionnaire. Younger age (per decade increase in odds ratio, 0.64; 95% 
confidence interval, 0.45–0.91) and having previous anxiety/depression (odds ratio, 4.38; 95% confidence interval, 1.94–
9.89) were predictors for anxiety poststroke/transient ischemic attack. Participants with anxiety disorder were more 
dependent (modified Rankin Scale score 3–5, [anxiety] 55% versus [no anxiety] 29%; P<0.0005), had poorer quality of 
life on EQ-5D5L, and restricted participation (Work and Social Adjustment Scale: median, interquartile range, [anxiety] 
19.5, 10–27 versus [no anxiety] 0, 0–5; P<0.001).
Conclusions—Anxiety after stroke/transient ischemic attack is predominantly phobic and is associated with poorer patient 
outcomes. Trials of anxiety intervention in stroke should consider the different treatment approaches needed for phobic 
and generalized anxiety.   (Stroke. 2018;49:00-00. DOI: 10.1161/STROKEAHA.117.020078.)
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Anxiety is common, affecting around a quarter of stroke1 and nearly a third of transient ischemic attack (TIA).2 It can 
hamper stroke rehabilitation effort and prevent patients from 
returning to their usual activities. Despite earlier observations 
that phobic anxiety might be present after stroke,3–5 intervention 
studies have treated anxiety poststroke as one unitary phenom-
enon and evaluated general approaches, such as relaxation and 
antidepressants,6 which are unlikely to be effective in phobic 
anxiety. Clinical trials have not yielded any definitive evidence 
to guide treatment for anxiety after stroke.6 It is well recognized 
in nonstroke populations that phobic disorder and generalized 
anxiety disorder (GAD) need different treatment approaches.
Phobic and Generalized Anxiety
Phobic anxiety is characterized by a disproportionate fear 
of well-defined situations or stimuli.7 Exposure to the feared 
situation triggers unpleasant anxiety symptoms, accompa-
nied by marked avoidant behavior of that feared situation: the 
hallmark of phobic anxiety.7 Although avoidant behavior may 
relieve anxiety in the short term, it can become disabling if 
the behavior becomes consolidated through conditioning; for 
example, becoming housebound in agoraphobia as a result of 
learning to associate danger with leaving house. Treatment of 
phobic disorders requires systematic, repeated, hierarchical 
exposure to the specific anxiety-provoking stimulus.8 By con-
trast, GAD is diffuse and unremitting, characterized by persis-
tent and multiple worries; for example, finances, health, and 
an inability to stop worrying.7 Selective serotonin-reuptake 
inhibitors, benzodiazepines (in short term only), and other 
cognitive behavioral therapy (CBT) techniques, for example, 
cognitive restructuring and problem solving, are effective at 
treating GAD.9,10
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Our Aims
To determine the target for anxiety treatment after stroke, we 
need to know the proportions of anxiety subtypes; if phobic, the 
specific stimuli; the predictors for anxiety; the impact of anxiety 
on functional outcomes and quality of life. We aimed to report 
(1) the frequency of phobic disorder and GAD at 3 months after 
stroke and TIA, (2) avoidant behavior of specific anxiety-provok-
ing situations, (3) the predictors of anxiety, and (4) the associa-
tions with dependence, quality of life, and social participation.
Methods
The data that support the findings of this study are available from 
the corresponding author on reasonable request as per the journal’s 
Transparency and Openness Promotion Guidelines.
Sampling and Recruitment
Prospective Recruitment
We screened consecutive eligible patients admitted to the acute stroke 
unit and TIA clinics in National Health Service Lothian—the sole pro-
vider of stroke and TIA services for the city of Edinburgh, Midlothian, 
and East Lothian regions in Scotland, between September 9, 2015, 
and June 28, 2016. We included participants who (1) were aged ≥18, 
(2) had a new clinical diagnosis of stroke or definite or probable TIA, 
(3) had mental capacity to give informed consent, and (4) were able 
to communicate in English on the telephone. We excluded patients 
with subarachnoid hemorrhage, subdural and extradural hematoma, 
ocular TIA, patients at terminal stage of life, or who were difficult to 
follow-up–no fixed abode, current illicit, or alcohol dependence
Definitions of Stroke and TIA
We used clinical diagnosis of stroke or TIA made by consultant 
stroke clinicians according to the following: stroke—the sudden loss 
of focal cerebral function, lasting ≥24 hours, thought to be caused 
by an inadequate blood supply to part of the brain (ischemic stroke), 
or spontaneous hemorrhage into the brain substance (primary intra-
cerebral hemorrhagic), where brain imaging was normal or showed 
evidence of recent ischemia or hemorrhage11; TIA—a clinical time-
based definition of symptoms lasting <24 hours; TIA was definite 
when a diagnosis of TIA was the only one considered for the symp-
toms and probable when a TIA was the most likely of several dif-
ferential diagnoses.
Baseline Characteristics
We used hospital electronic health records to gather data on age, 
sex, diagnosis on discharge, vascular territory of stroke/TIA, and the 
National Institutes of Health Stroke Scale score—a measure of neuro-
logical impairment on admission.12 We assigned a National Institutes 
of Health Stroke Scale of zero to all TIAs. We recorded whether the 
participants lived alone prestroke or TIA, had a history of stroke or 
ischemic heart disease, and past diagnosis of anxiety or depression 
by checking the electronic heath records first, then confirmed at the 
time of interview.
Assessment of Anxiety and Other 
Neuropsychiatric Disorders
At 3 months, a trained member of medical staff (H.-Y.Y.C.) per-
formed a semistructured psychiatric interview (SCID) using the 
telephone version of the Structured Clinical Interview for Diagnostic 
Statistical Manual-IV-Text Revision of mental disorders.13 The 
SCID has fair-to-excellent interrater agreement for diagnosing both 
anxiety disorders and depression between experienced and newly 
trained clinicians14 and between its telephone and face-to-face ver-
sions.15 The following conditions were screened using the relevant 
SCID modules: panic disorder, agoraphobia, social phobia, specific 
phobia, GAD, obsessive-compulsive disorder, post-traumatic stress 
disorder (PTSD), and minor and major depressive episodes. All SCID 
diagnoses were made according to the SCID coding system and after 
confirmation with a consultant neuropsychiatrist (A.J.C.) at weekly 
meetings. Participants who were unable to talk on the telephone had 
face-to-face interviews at home or at an outpatient clinic. We mea-
sured cognition with the telephone Montreal Cognitive Assessment.16
Assessment of Avoidant Behavior in 
Specific Anxiety-Provoking Situations
One week before the SCID interview, we sent the participant a Fear 
Questionnaire (FQ) for completion by post or online. The FQ con-
sists of an agoraphobic subscale (5 items), a social phobia subscale 
(5 items), and a blood/injury phobia subscale (5 items).17 Each item 
denotes a situation and is rated according to the level of avoidance 
from zero (would not avoid it) to 8 (always avoid it). We replaced the 
blood/injury items with 6 other specific situations that we encoun-
tered in our clinical practice—(1) physical exertion, (2) having sex, 
(3) being alone at home, and any of your normal day-to-day activi-
ties for fear of having (4) a headache (5) another stroke, or (6) a fall. 
During the interview, we also recorded positive responses to a list of 
11 predefined anxiety-provoking stimuli, similar to the ones on the 
FQ (Table I in the online-only Data Supplement). We derived these 
additional anxiety-provoking stimuli from the shared clinical expe-
rience of our multidisciplinary stroke team in neuropsychiatry and 
postacute stroke settings.
Potential Predictors for Anxiety Disorder 
at 3 Months After Stroke/TIA
We prespecified age, sex, living alone prestroke/TIA, and a past diag-
nosis of anxiety or depression as potential predictors for having anxi-
ety disorder at 3 months after stroke/TIA.
Measures of Dependence, Quality of 
Life, and Social Participation
Measures of dependence, quality of life, and social participation were 
completed at the time of SCID with the modified Rankin Scale,18 the 
EuroQoL-5D5L,19 and the Work and Social Adjustment Scale.20
Statistical Analyses
We used descriptive statistics to summarize data, exact confidence 
intervals for proportions, and univariable and multivariable logistic 
regression to calculate unadjusted and adjusted odds ratios for asso-
ciations. Group differences were assessed using univariable logistic 
regression, t tests, and Mann–Whitney U tests as appropriate to data 
type. Only returned FQs were analyzed for avoidant behavior. All 
items on the online questionnaire must be scored to permit submis-
sion, preventing any unscored items. Any unscored item on a returned 
postal questionnaire was given the most conservative interpretation 
and imputed zero, assuming that the item was irrelevant or did not 
elicit any anxiety symptoms. We performed all statistical analy-
ses using STATA14.21 We aimed for a target sample size of ≈200 to 
achieve a desired precision of ±0.05 around our estimated frequency 
of poststroke anxiety of 0.20.
Reporting Standards and Ethics Approval
We reported the study in accordance with Strengthening the Reporting 
of Observational Studies in Epidemiology guidelines. We obtained 
approval from the South East Scotland Research Ethics Committee 
(15/SS/0087) on September 1, 2015. All participants gave written 
informed consent.
Results
We recruited 201 participants between September 9, 2015, and 
June 28, 2016. Twenty-six of 201 participants did not have 
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Table 1. Baseline Characteristics of Sample, by Anxiety Disorder at 3 Months
No. of Patients
Prospective Cohort SCID Diagnosis Univariable Logistic Regression
All Any Anxiety Disorder No Anxiety Disorder
OR 95% CI
Likelihood 
Ratio Test175 38 22% 137 78%
Demographics
  Age, y; mean (SD) 69.6 (11.6) 64.2 (12.3) 71.0 (10.9)    
  Age group, y 
   <65 62 35% 23 61% 39 28% 1  P=0.001*
   65–75 55 31% 6 16% 49 36% 0.21  0.08–0.56
   >75 58 33% 9 24% 49 36% 0.31 0.13–0.75
  Sex 
   Women 70 40% 18 47% 52 38% 1.47 0.71–3.04 P=0.298
   Men 105 60% 20 53% 85 62% 1  
Recruitment setting
  Clinic 95 54% 21 55% 74 54% 1  P=0.891
  Acute stroke unit 80 46% 17 45% 63 46% 1.05 0.51–2.17
Diagnosis
  Ischemic stroke 109 62% 24 63% 85 62% 1  P=0.140
  Primary intracerebral hemorrhage 5 3% 3 8% 2 1% 5.31 0.84–33.6
  TIA (probable or definite) 61 35% 11 29% 50 36% 0.78 0.35–1.72
Hemisphere of stroke/TIA symptoms
  Left anterior circulation 82 47% 17 45% 65 47% 1  P=0.662
  Right anterior circulation 53 30% 13 34% 40 29% 1.24 0.55–2.83
  Posterior circulation 35 20% 6 16% 29 21% 0.79 0.28–2.21
  Uncertain 5 3% 2 5% 3 2% 2.55 0.03–16.49
Neurological impairment (NIHSS)
  Median (IQR) 0 (0–2) 0 (0–2) 0 (0–2)    
  TIA 61 35% 11 29% 50 36% 1  P=0.575
  Stroke, NIHSS         
   0 30 17% 9 24% 21 15% 1.95 0.70–5.39
   1–4 71 41% 16 42% 55 40% 1.32 0.56–3.11
   >4 13 7% 2 5% 11 8% 0.83 0.16–4.27
Prestroke status
  Lived alone before stroke/TIA
   Yes 60 34% 15 39% 45 33% 1.33 0.64–2.80 P=0.450
   No 115 66% 23 61% 92 67% 1   
  Independent before stroke/TIA
   Yes 169 97% 37 97% 132 96% 1.4 0.16–12.37 P=0.753
   No 6 3% 1 3% 5 4% 1  
Past diagnosis of depression or anxiety disorder
  None 123 70% 15 39% 108 79% 1  P<0.001*
  Depression only 30 17% 10 26% 20 15% 3.6 1.42–9.14
  Anxiety only 11 6% 6 16% 5 4% 8.64 2.35–31.83
  Both depression and anxiety 11 6% 7 18% 4 3% 12.6 3.29–48.21
(Continued )
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SCID at 3 months—3 had died, 1 was on palliation for termi-
nal cancer, 4 had lost mental capacity, 9 withdrew consent for 
SCID, and 9 were not contactable (Figure I in the online-only 
Data Supplement). Participants lost to follow-up were more 
likely to live alone (losses: 15 of 26, 58%; analyzed: 60 of 175, 
34%; P=0.024); otherwise, they were similar to those who 
were analyzed (Table II in the online-only Data Supplement). 
In the analyzed sample (Table 1), 175 participants (mean age 
[SD], 70 [12]; women, 70 of 175; 40%) had SCID at 3 months 
poststroke/TIA. The majority had ischemic stroke, a third had 
TIA, and few had primary intracerebral hemorrhage (ischemic 
stroke: 109 of 175, 62%; TIA: 61 of 175, 35%; primary intrace-
rebral hemorrhage: 5 of 175, 3%). We recruited similar numbers 
from the acute stroke unit and TIA clinic (acute stroke unit: 80 
of 175, 46%; TIA clinics: 95 of 175, 54%). Our sample, there-
fore, consisted of patients with mild stroke and TIA (National 
Institutes of Health Stroke Scale: median [interquartile range], 
0 [0–2]). Nearly all participants were interviewed by telephone 
(telephone: 168 of 175, 96%; face to face: 7 of 175, 4%).
Frequency of Anxiety Disorders and Psychiatric 
Comorbidity at 3 Months After Stroke/TIA
A fifth of our sample had at least 1 anxiety disorder at 3 
months after stroke/TIA (38 of 175, 22% [95% confidence 
interval, 16–29]). Phobic disorder was the most frequent anxi-
ety subtype (phobic disorder only: 18 of 175, 10%; both pho-
bic disorder and GAD: 13 of 175, 7%; GAD only: 7 of 175, 
4%; Figure 1A; Table 2). PTSD appeared as a comorbidity in 
phobic disorder-only cases (6 of 18), GAD-only cases (1 of 7), 
and both phobic disorder and GAD cases (4 of 13; Table 2). 
Half of all people with anxiety disorder also had a minor or 
major depressive episode (20 of 38, 53%; Figure 1B). We found 
no difference in cognitive function between patients with anxi-
ety disorder and those without (telephone Montreal Cognitive 
Assessment median, interquartile range: [anxiety disorder] 18, 
16–21; [no anxiety disorder] 19, 17–20; P=0.692). Of the TIA 
patients, 18% (11 of 61) had an anxiety disorder, 10% (6 of 61) 
had phobic disorder only, 3% (2 of 61) had both phobic disor-
der and GAD, and 5% (3 of 61) had GAD only.
Avoidant Behavior and Anxiety-
Provoking Situations/Stimuli
Eighty-four percent (147 of 175) returned completed FQ for 
analysis. Nonresponders were younger than the FQ sample 
analyzed (mean age: nonresponders, 64.8±14.9; FQ analyzed, 
70.5±10.6; P=0.017) but did not differ statistically in other 
characteristics (Table III in the online-only Data Supplement). 
Participants with an anxiety disorder at 3 months reported sig-
nificantly higher level of avoidant behavior across all situa-
tions on the FQ compared with participants without (Figure 2). 
Similarly, during SCID, positive responses to all of the 11 
predefined situations were more common in participants with 
anxiety disorder compared with those without (Figure II in the 
online-only Data Supplement). The fear of stroke recurrence 
had the most positive responses in those with anxiety disorder 
(31 of 38; 82%) and in those without (40 of 137; 29%). We 
Figure 1. A, Number of cases (sample fre-
quency) of phobic disorder and GAD, (B) 
comorbid depression in sample at 3 months 
(n=175). GAD indicates generalized anxiety 
disorder.
Table 1. Continued
No. of Patients
Prospective Cohort SCID Diagnosis Univariable Logistic Regression
All Any Anxiety Disorder No Anxiety Disorder
OR 95% CI
Likelihood 
Ratio Test175 38 22% 137 78%
History of stroke 
  Yes 22 13% 7 18% 15 11% 1.84 0.69–4.89 P=0.237
  No 153 87% 31 82% 122 89% 1   
History of ischemic heart disease 
  Yes 30 17% 8 21% 22 16% 1.39 0.56–3.44 P=0.479
  No 145 82% 30 79% 115 84% 1   
CI indicates confidence interval; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; SCID, Structured Clinical 
Interview for Diagnostic Statistical Manual-IV-Text Revision; and TIA, transient ischemic attack.
*P<0.05.
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listed any additional anxiety-provoking situations reported 
during SCID (Table IV in the online-only Data Supplement).
Associations With Dependence, Health-Related 
Quality of Life, and Social Participation at 3 Months
Despite similar baseline neurological impairment (National 
Institutes of Health Stroke Scale 0–4, [anxiety disorder] 95% 
versus [no anxiety disorder] 92%; P=0.575), participants 
with anxiety disorder were more dependent (modified Rankin 
Scale score 3–5, [anxiety disorder] 55% versus [no anxiety 
disorder] 29%; P<0.0005), reported more problems across 
all health-related quality of life domains on the EQ-5D5L 
(Figure 3), and more restriction in social participation (Work 
and Social Adjustment Scale: median, interquartile range: 
[anxiety disorder] 19.5, 10–27; [no anxiety disorder] 0, 0–5; 
P<0.001).
Predictors of Anxiety Disorder at 
3 Months After Stroke/TIA
The odds of having an anxiety disorder at 3 months after 
stroke or TIA decreased by a third per decade increase in 
age (adjusted odds ratio, 0.64; 95% confidence interval, 
0.45–0.91) and increased 4-fold when there was a past diag-
nosis of anxiety or depression (adjusted odds ratio, 4.38; 95% 
confidence interval, 1.94–9.89; Table 3). Sex or living alone 
prestroke/TIA were not statistically associated with anxiety 
disorder at 3 months.
Discussion
Key Findings
In our sample of stroke and TIA patients, a fifth had an anxiety 
disorder diagnosed at psychiatric interview at 3 months. We 
found phobic disorder to be the predominant anxiety subtype 
after stroke or TIA. Anxious patients reported more avoidance 
in agoraphobia-related, social, and other specific situations or 
stimuli—physical exertion, having sex, being alone at home, 
activities related to fear of having a headache, another stroke, 
or a fall. PTSD was more common than we had anticipated. 
Younger age and having a history of anxiety or depression 
increased the likelihood of developing anxiety poststroke/
TIA. Despite having a similar level of neurological impair-
ment at baseline, participants with anxiety disorder were more 
dependent, had poorer health-related quality of life, and were 
more restricted in social participation at 3 months after stroke 
or TIA compared with those without anxiety disorder.
Potential Bias in Our Methodology
Our trained interviewer was a stroke clinician who received 
training in performing the SCID. We minimized any variability 
in diagnosis by having all final diagnoses discussed and con-
firmed with a consultant neuropsychiatrist at weekly meetings. 
A systematic review of studies assessing the agreement between 
diagnostic telephone and face-to-face psychiatric interviews 
found good agreement (κ=0.69–0.84) between the 2 versions in 
psychiatric populations,22 supporting the use of telephone SCID 
for anxiety disorders and depression. However, there are no 
such comparability data in stroke. The use of telephone SCID 
in our study could have influenced the accuracy of the true 
estimates of our SCID diagnoses. SCID diagnosis was made 
based on formal diagnostic criteria and coding system, tak-
ing into account detailed narrative of the patient’s experience. 
Temporary distress experienced by the participant at the time 
of SCID, if any, was unlikely to influence the final diagnosis. 
Our final sample size of 175 fell short of the 200 we intended to 
recruit. This impacted slightly on the precision of our frequency 
estimate for any anxiety disorder, from ±0.05 to ±0.06.
We note a high proportion of previous anxiety or depression 
in our sample. Case ascertainment relied on participants’ rec-
ollection of any past diagnosis made throughout their lifetime, 
potentially leading to overestimates. We had losses to follow-
up in the prospective cohort. More people lived alone in the 
Table 2. Sample Frequencies of SCID-Diagnosed Phobic 
Disorder, GAD, and Psychiatric Comorbidity (n=175)
SCID Diagnosis Total (n=175)
Sample 
Frequency, %
95% Confidence 
Intervals
Any anxiety disorder 38 22 16–29
Phobic disorder only 18 10 6–16
  Comorbidity    
   Panic disorder 5 3 1–7
   PTSD 6 3 1–7
   OCD 0 0 0–2
   Depressive episode 
(minor+major)
7 4 2–8
GAD only 7 4 2–8
  Comorbidity    
   Panic disorder 2 1 0–4
   PTSD 1 0.5 0–3
   OCD 0 0 0–2
   Depressive episode 
(minor+major)
5 3 1–7
Both phobic disorder 
and GAD
13 7 4–12
  Comorbidity    
   Panic disorder 7 4 2–8
   PTSD 4 2 1–6
   OCD 2 1 0–4
   Depressive episode 
(minor+major)
8 5 2–9
All depressed (minor or 
major depressive)
27 15 11–22
  Depressed with an 
anxiety disorder
20 11 7–17
  Depressed without 
anxiety disorder
7 4 2–8
Not depressed 148 85 79–90
GAD indicates generalized anxiety disorder; OCD, obsessive-compulsive 
disorder; PTSD, Post-traumatic stress disorder; and SCID, Structured Clinical 
Interview for Diagnostic Statistical Manual-IV-Text Revision.
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losses compared with those who underwent SCID. This could 
have led to underestimates of anxiety disorder and depression 
because living alone is associated with a higher psychiatric 
morbidity in the general population.23 We lost FQ data through 
nonresponders, and they were younger compared with the FQ 
sample analyzed. Although over a quarter of participants com-
pleted the FQ online as their preferred method, we did not test 
the agreement between the 2 versions. Our population was at 
the milder end of the stroke spectrum.
Interpretation
Our frequency estimate falls within the range of frequencies 
reported in a recent meta-analysis of anxiety poststroke: 18% 
to 25%.1 We found phobic disorder to be the predominant 
anxiety subtype poststroke/TIA and quantified for the first 
time, the avoidant behavior of specific anxiety-provoking 
situations in people with anxiety poststroke/TIA. Our study 
is the first to have assessed the frequency of anxiety subtypes 
using diagnostic interview in TIA patients.24 Similar to our 
main analysis, phobic disorder was the most frequent anxiety 
subtype post-TIA. Our frequency estimate of anxiety disorder 
post-TIA is similar to that reported using a rating scale cutoff 
for definite anxiety in a regional stroke registry.2
Earlier studies suggested phobic anxiety might be present 
after stroke,3–5 yet clinical trials of anxiety intervention did 
not translate this finding, treating anxiety poststroke as a uni-
tary phenomenon. Thus far, only general approaches, such as 
relaxation and antidepressants, have been evaluated in stroke,6 
which are unlikely to be effective in patients with predomi-
nantly phobic anxiety. Our findings suggest the need to evalu-
ate exposure techniques—an approach known to be effective 
in phobic disorder in nonstroke populations8 but one that has 
never been evaluated in stroke. We identified the specific situa-
tions/stimuli avoided in our anxious participants, which could 
be potential targets for psychotherapy; for example, CBT.
Fear of Stroke Recurrence
The fear of stroke recurrence was the most commonly reported 
anxiety-provoking stimulus in our participants, with or without 
anxiety disorder. In our interviews, we found this anxious antic-
ipation—the experience of anxiety by thinking about an event in 
the future, to have led to differential behaviors in our participants. 
In some, this anticipatory anxiety brought about a desire for bet-
ter health and increased positive health behaviors; for example, 
complying to medications and doctor’s advice on lifestyle and 
giving up smoking. In others, this anticipatory anxiety became 
Figure 2. The thick lines represent median; boxes represent interquartile range; and whiskers represent range. Avoidant behavior in ago-
raphobic, social, and other specific situations (n=147). FQ indicates Fear Questionnaire.
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disproportionate and perpetuated maladaptive avoidant behaviors 
of specific situations; for example, travelling alone, crowds, phys-
ical exertion, and social gatherings. The fear of stroke recurrence, 
accompanied by a sense of complete loss of control in a public 
place, seemed to underlie the agoraphobia in our participants. 
These maladaptive thinking patterns and avoidant behaviors are 
potential targets for cognitive restructuring and exposure therapy 
in a CBT intervention. In exposure therapy, phobic patients 
confront their specific feared situation in a graduated hierarchi-
cal fashion, until the unpleasant anxiety feelings diminish. The 
individual’s realization that catastrophe has not occurred, despite 
confronting his/her feared situation, for example, taking the bus, 
can be used to help challenge a maladaptive belief; for example, 
“I am going to have a stroke if I travel on the bus.”
Figure 3. Baseline NIHSS, mRS and EuroQoL 5D-5L domains, by anxiety disorder at 3 months post-stroke/TIA (n=175). mRS indicates 
modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and EQ5D-5L, EuroQoL-5D5L.
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Psychiatric Comorbidity
Psychiatric comorbidity in our sample was common, and its 
symptoms should be considered in the treatment of anxiety 
poststroke/TIA. Few studies have estimated the frequency 
of clinical diagnosis of PTSD poststroke/TIA.25 Like phobic 
and generalized anxiety, PTSD has specific treatment strate-
gies in nonstroke populations—trauma-focused CBT and eye 
movement reprocessing.26,27 These now need to be tested in 
stroke. Our finding on PTSD adds weight to our general thesis 
that treating anxiety as a unitary condition after stroke will 
lessen the likelihood of finding effective treatments. In PTSD, 
individuals persistently reexperience the traumatic event in 
the form of distressing flashbacks, intrusive thoughts, and 
nightmares.7 In our cases of PTSD, emotional distress was 
provoked by bodily sensations or situations that reminded 
the individuals of their index event; for example, headaches, 
odd sensation in affected limb, and meeting people who were 
likely to enquire about the index event. Panic disorder was 
nested within our phobic and GAD cases. It refers to a ten-
dency to have panic attacks—the most extreme and unpleas-
ant form of anxiety state with marked autonomic symptoms 
and the feeling of impending catastrophe. Panic disorder is 
usually managed with CBT or medications.
Consistent with the literature,1,28 concurrent depression was 
common among anxiety cases, reaffirming the need to manage 
depression in those with anxiety poststroke. Our frequency 
estimate of poststroke depression was half of what is usually 
reported.29 This is probably because our sample consisted of 
mainly mild stroke and TIA patients and that stroke severity 
and physical disability are the most consistent predictors for 
poststroke depression.30
Predictors of Anxiety Poststroke/TIA
The likelihood of developing anxiety after stroke or TIA 
increased in younger people and in those with a history of anxi-
ety or depression, consistent with anxiety in the general popula-
tion. In contrast to the general population, men were as likely as 
women to develop anxiety poststroke/TIA. We found no asso-
ciation between lesion location and anxiety poststroke/TIA.
Associations With Dependence, Quality 
of Life, and Social Participation
Our study findings on dependence, quality of life, and social 
participation challenge the pervasive view among stroke clini-
cians that these patients are not disabled by their seemingly 
minor cerebrovascular event. Anxiety disorders, PTSD, and 
depression can be profoundly disabling and need to be consid-
ered as important outcomes in stroke and TIA.
Implications for Future Research
The lack of evidence-based anxiety interventions is a barrier 
to improving outcomes in patients with anxiety poststroke/
TIA. Trialists must recognize the need for different treatment 
approaches for phobic and generalized anxiety. Given the 
predominance of phobic disorder poststroke/TIA, exposure 
therapy needs to be evaluated in a clinical trial in this popula-
tion. Individually tailored CBT (augmented CBT) is feasible 
in clinical trial setting of poststroke depression31,32 and may be 
similarly applied in anxiety poststroke/TIA.
Generalizability
Our sample is different from the population of patients with 
stroke, in that all our participants could communicate by tele-
phone, hence in general had mild deficits. Based on the Scottish 
Stroke Care Audit registry data, we would expect around a fifth 
of the National Health Service Lothian stroke population to 
have communication difficulties. Furthermore, competing 
research studies were recruiting patients with more severe defi-
cits at the same time as this study’s recruitment. We recruited 
half of our sample from clinic where patients tended to have 
mild or resolution of neurological symptoms. We, therefore, 
consider our sample as representative of the mild stroke and 
TIA population with limited generalizability to severe stroke 
or those who have significant communication difficulties. The 
telephone Montreal Cognitive Assessment scores in our sam-
ple are consistent with findings in a similar sample of stroke 
and TIA patients16 and suggest the presence of mild cognitive 
impairment—a known manifestation of mild stroke and TIA.33
Conclusions
Phobic disorder is the predominant anxiety subtype and can 
occur in the absence of GAD after a mild stroke or TIA. 
Future trials of anxiety intervention in stroke must consider 
the presence of phobic disorder and should consider the use of 
exposure therapy techniques and augmented CBT.
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